Problems in the "evidence" of "evidence-based medicine"

The American Journal of Medicine
A R Feinstein, R I Horwitz

Abstract

The proposed practice of "evidence-based medicine," which calls for careful clinical judgment in evaluating the "best available evidence," should be differentiated from the special collection of data regarded as suitable evidence. Although the proposed practice does not seem new, the new collection of "best available" information has major constraints for the care of individual patients. Derived almost exclusively from randomized trials and meta-analyses, the data do not include many types of treatments or patients seen in clinical practice; and the results show comparative efficacy of treatment for an "average" randomized patient, not for pertinent subgroups formed by such cogent clinical features as severity of symptoms, illness, co-morbidity, and other clinical nuances. The intention-to-treat analyses do not reflect important post-randomization events leading to altered treatment; and the results seldom provide suitable background data when therapy is given prophylactically rather than remedially, or when therapeutic advantages are equivocal. Randomized trial information is also seldom available for issues in etiology, diagnosis, and prognosis, and for clinical decisions that depend on pathophysiologic changes, psychosocial ...Continue Reading

References

Nov 4, 1992·JAMA : the Journal of the American Medical Association·UNKNOWN Evidence-Based Medicine Working Group
Mar 1, 1992·Journal of Clinical Epidemiology·A S DetskyK A L'Abbé
Jun 1, 1992·Journal of Clinical Epidemiology·J G Elmore, A R Feinstein
Jun 26, 1986·The New England Journal of Medicine·S H CroogG H Williams
Nov 11, 1995·Lancet·I Chalmers
May 1, 1995·Annals of Internal Medicine·F DavidoffP W Fried
Dec 3, 1994·BMJ : British Medical Journal·D L Sackett
Oct 1, 1994·BMJ : British Medical Journal·I Chalmers, B Haynes
Jan 1, 1994·International Journal of Health Services : Planning, Administration, Evaluation·R Chernomas, A Sepehri
Jan 13, 1996·BMJ : British Medical Journal·D L SackettW S Richardson
Dec 27, 1995·JAMA : the Journal of the American Medical Association·L Bero, D Rennie
Apr 5, 1996·Science·G Taubes
Sep 21, 1996·BMJ : British Medical Journal·S J SharpD G Altman

❮ Previous
Next ❯

Citations

Jan 5, 2002·The Journal of Orthopaedic and Sports Physical Therapy·M T Cibulka, K Aslin
Jul 31, 2002·Lancet·David W RobertsonRoss Upshur
Feb 25, 2014·Diabetes & Metabolism·G Reach
Dec 21, 2002·Journal of Clinical Periodontology·P Sjögren, A Halling
Jul 22, 2010·Nutrition Reviews·Jeffrey BlumbergSteven H Zeisel
Apr 28, 2004·Journal of General Internal Medicine·Brian P LucasJeremy P Smith
Jan 12, 2010·International Journal of Technology Assessment in Health Care·Sheila HarveyNick Black
Sep 2, 2000·Journal of Evaluation in Clinical Practice·B DjulbegovicG H Lyman
Aug 16, 2002·Journal of Evaluation in Clinical Practice·Ross E G Upshur
Feb 2, 1999·Journal of Evaluation in Clinical Practice·E Shahar
Feb 18, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·T L Diepgen, H C Williams
Jan 9, 2001·Journal of Clinical Epidemiology·G B Hill
Jun 14, 2002·Journal of Clinical Epidemiology·Ioannis A GiannakakisJohn P A Ioannidis
Feb 3, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Tuan V Nguyen
Sep 17, 2003·Journal of Manipulative and Physiological Therapeutics·Anthony Rosner
Oct 9, 2002·Acta Psychiatrica Scandinavica. Supplementum·C D Bilsbury, A Richman
Feb 20, 2002·Journal of Advanced Nursing·Peter French
Aug 10, 2000·Anesthesiology Clinics of North America·P J Hoehner
May 19, 2001·Clinical Implant Dentistry and Related Research·M L Barnett
Jun 18, 2005·Journal of Fluency Disorders·Nan Bernstein Ratner
Mar 21, 2002·The British Journal of Dermatology·J R Rees
Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Elizabeth H Logue
Jan 12, 2000·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·D Eskinazi, D Muehsam
Apr 28, 2000·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·N C Abbot
Feb 1, 2007·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Christian WillyMichael Engelhardt
Nov 28, 2001·Clinical and Experimental Dermatology·H Williams
Jul 12, 2003·Teaching and Learning in Medicine·Rosanne M LeipzigThomas McGinn
Aug 14, 2003·Best Practice & Research. Clinical Rheumatology·Theodore Pincus, Tuulikki Sokka
Jun 13, 1998·The New England Journal of Medicine·C L Cole
Jun 26, 2001·International Journal of Dermatology·R Marks
Jun 16, 1999·International Journal of Dermatology·R Marks
Jan 11, 2000·Image--the Journal of Nursing Scholarship·M A Rosswurm, J H Larrabee
Mar 7, 2002·Health Policy·José M QuintanaBegoña Goikoetxea
Sep 8, 2010·Expert Review of Neurotherapeutics·Vinod Kumar Gupta
Mar 1, 2005·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Donna Seger
Oct 1, 2014·Journal of Evaluation in Clinical Practice·Jeannette Hofmeijer
Jan 23, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Clementine NordonUNKNOWN GetReal consortium
Jan 5, 2016·Journal of Evaluation in Clinical Practice·Shashi S Seshia
Mar 20, 2013·Clinics in Plastic Surgery·Evan Kowalski, Kevin C Chung
Nov 6, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Giovanni A FavaEliana Tossani
May 13, 1999·Mayo Clinic Proceedings·J T Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

QJM : Monthly Journal of the Association of Physicians
F P Sarasin
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
Karina W DavidsonEvelyn P Whitlock
Journal of Developmental and Behavioral Pediatrics : JDBP
J H Kennell
Clinical Trials : Journal of the Society for Clinical Trials
Miguel A Hernán, Sonia Hernández-Díaz
© 2021 Meta ULC. All rights reserved